RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression

RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression

Interleukin-17 (IL-17)-producing helper T cells (Th17 cells) play an important role in autoimmune diseases. However, not all Th17 cells induce tissue inflammation or autoimmunity. Th17 cells require IL-23 receptor (IL-23R) signaling to become pathogenic. The transcriptional mechanisms controlling th...

Descripció completa

Dades bibliogràfiques
Autors principals:	Gerd Meyer zu Horste, Chuan Wu, Chao Wang, Le Cong, Mathias Pawlak, Youjin Lee, Wassim Elyaman, Sheng Xiao, Aviv Regev, Vijay K. Kuchroo
Format:	Article
Idioma:	English
Publicat:	Elsevier 2016-07-01
Col·lecció:	Cell Reports
Matèries:	Th17 cells pathogenicity IL-23R RBPJ Notch
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S221112471630701X

Ítems similars

RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression
per: Meyer zu Horste, Gerd, et al.
Publicat: (2017)

Pathological pericyte expansion and impaired endothelial cell-pericyte communication in endothelial Rbpj deficient brain arteriovenous malformation
per: Samantha Selhorst, et al.
Publicat: (2022-09-01)

SUMOylated non-canonical polycomb PRC1.6 complex as a prerequisite for recruitment of transcription factor RBPJ
per: Małgorzata Sotomska, et al.
Publicat: (2021-07-01)

Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy
per: Mengjie Rui, et al.
Publicat: (2022-04-01)

An RBPJ-<i>Drosophila</i> Model Reveals Dependence of RBPJ Protein Stability on the Formation of Transcription–Regulator Complexes
per: Bernd M. Gahr, et al.
Publicat: (2019-10-01)

The expression of RBPJ and its potential role in rheumatoid arthritis
per: Shuaishuai Chen, et al.
Publicat: (2024-09-01)

CNS resident macrophages exhibit region-specific states and immunogenic responses during Rbpj-deficient brain arteriovenous malformation
per: Sera Nakisli, et al.
Publicat: (2025-01-01)

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
per: Claudia Schinocca, et al.
Publicat: (2021-02-01)

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
per: Taoming Liu, et al.
Publicat: (2020-11-01)

Exosomal LncRNA LBX1-AS1 Derived From RBPJ Overexpressed-Macrophages Inhibits Oral Squamous Cell Carcinoma Progress via miR-182-5p/FOXO3
per: Yilong Ai, et al.
Publicat: (2021-03-01)

Increased IL-23R+ Th Cells Population Exhibits Higher SLEDAI-2K Scores in Systemic Lupus Erythematosus Patients
per: Aziz Farah Izati, et al.
Publicat: (2021-08-01)

Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
per: Hélène Bugaut, et al.
Publicat: (2021-02-01)

No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors
per: Hua Zhang, et al.
Publicat: (2022-02-01)

The effect of periodontal therapy on IL-17 and IL-23 in Gingival Crevicular Fluid (GCF) of patients with severe periodontitis
per: Marzieh Rohaninasab, et al.
Publicat: (2013-03-01)

The effect of periodontal therapy on IL-17 and IL-23 in Gingival Crevicular Fluid (GCF) of patients with severe periodontitis
per: Marzieh Rohaninasab, et al.
Publicat: (2013-03-01)

miR-375 upregulates lipid metabolism and inhibits cell proliferation involved in chicken fatty liver formation and inheritance via targeting recombination signal binding protein for immunoglobulin kappa J region (RBPJ)
per: Yong-Hong Zhang, et al.
Publicat: (2023-01-01)

Th17-Inducing Cytokines IL-6 and IL-23 Are Crucial for Granuloma Formation during Experimental Paracoccidioidomycosis
per: Fabrine Sales Massafera Tristão, et al.
Publicat: (2017-08-01)

IL-17A, IL-17F and IL-23 in patients with rheumatoid arthritis
per: Natalia A. Lapkina, et al.
Publicat: (2024-09-01)

Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
per: Haitham M. Saad, et al.
Publicat: (2024-12-01)

The regulatory mechanism and potential application of IL-23 in autoimmune diseases
per: De-Kai Xiong, et al.
Publicat: (2022-09-01)

IL-23/Th17 pathway and IL-17A gene polymorphism in Egyptian children with immune thrombocbytopenic purpura
per: Ahlam M. Ismail, et al.
Publicat: (2021-08-01)

Diagnostic value of interleukins 23 and 17 in the assessment of ulcerative colitis severity
per: M.V. Stoikevych, et al.
Publicat: (2024-12-01)

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
per: Victoria Navarro-Compán, et al.
Publicat: (2023-08-01)

Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
per: Victoria Navarro-Compán, et al.
Publicat: (2023-11-01)

IL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice
per: Daniel Engelbertsen, et al.
Publicat: (2018-04-01)

The inflammatory cytokine interleukin-23 is elevated in lung cancer, particularly small cell type
per: Caner Cam, et al.
Publicat: (2016-08-01)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
per: Cauli A, et al.
Publicat: (2015-10-01)

Regulatory effects of C5a on IL-17A, IL-17F, and IL-23
per: Jamison J. Grailer, et al.
Publicat: (2013-01-01)

Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients
per: Mao Qing, et al.
Publicat: (2011-04-01)

IL-15 negatively regulates curdlan-induced IL-23 production by human monocyte-derived dendritic cells and subsequent Th17 response
per: Ahmet Eken, et al.
Publicat: (2019-11-01)

Effects of Cyclosporine on Palmoplantar Pustulosis and Serum Expression of IL-17, IL-23, and TNF-α
per: Xian-Hua Jin, et al.
Publicat: (2019-06-01)

Genetic Variants of the IL‐23/IL‐17 Axis and Its Association With Periodontal Disease: A Systematic Review
per: Ruth Rodríguez‐Montaño, et al.
Publicat: (2025-02-01)

Niosomal Curcumin Suppresses IL17/IL23 Immunopathogenic Axis in Skin Lesions of Psoriatic Patients: A Pilot Randomized Controlled Trial
per: Hanieh Kolahdooz, et al.
Publicat: (2023-04-01)

Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients
per: Hulya Deveci, et al.
Publicat: (2020-01-01)

Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study
per: Luigi Gargiulo, et al.
Publicat: (2024-10-01)

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
per: Dennis McGonagle, et al.
Publicat: (2021-03-01)

Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris
per: Luca Potestio, et al.
Publicat: (2024-07-01)

Expression of il-23/th17 pathway in a murine model of coxsackie virus b3-induced viral myocarditis
per: Kong Qing, et al.
Publicat: (2011-06-01)

Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
per: Gloria Pastor-Fernández, et al.
Publicat: (2020-09-01)

IL-23 Expression in Stewart-Treves Syndrome: Two Case Reports and Immunohistochemical Investigation
per: Saaya Yoshida, et al.
Publicat: (2020-04-01)